These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 20852848)

  • 1. The effects of nociceptin/orphanin FQ receptor agonist Ro 64-6198 and diazepam on antinociception and remifentanil self-administration in rhesus monkeys.
    Podlesnik CA; Ko MC; Winger G; Wichmann J; Prinssen EP; Woods JH
    Psychopharmacology (Berl); 2011 Jan; 213(1):53-60. PubMed ID: 20852848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the Discriminative Stimulus Effects of a NOP Receptor Agonist Ro 64-6198 in Rhesus Monkeys.
    Saccone PA; Zelenock KA; Lindsey AM; Sulima A; Rice KC; Prinssen EP; Wichmann J; Woods JH
    J Pharmacol Exp Ther; 2016 Apr; 357(1):17-23. PubMed ID: 26801398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys.
    Ko MC; Woods JH; Fantegrossi WE; Galuska CM; Wichmann J; Prinssen EP
    Neuropsychopharmacology; 2009 Aug; 34(9):2088-96. PubMed ID: 19279568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further characterization of the prototypical nociceptin/orphanin FQ peptide receptor agonist Ro 64-6198 in rodent models of conflict anxiety and despair.
    Goeldner C; Spooren W; Wichmann J; Prinssen EP
    Psychopharmacology (Berl); 2012 Jul; 222(2):203-14. PubMed ID: 22249359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of mu-opioid agonist efficacy on antinociceptive interactions between mu agonists and the nociceptin opioid peptide agonist Ro 64-6198 in rhesus monkeys.
    Cornelissen JC; Steele FF; Tenney RD; Obeng S; Rice KC; Zhang Y; Banks ML
    Eur J Pharmacol; 2019 Feb; 844():175-182. PubMed ID: 30552903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nociceptin/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin/orphanin FQ/mu-opioid receptor agonists.
    Khroyan TV; Polgar WE; Jiang F; Zaveri NT; Toll L
    J Pharmacol Exp Ther; 2009 Dec; 331(3):946-53. PubMed ID: 19713488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mu-opioid peptide (MOP) and nociceptin/orphanin FQ peptide (NOP) receptor activation both contribute to the discriminative stimulus properties of cebranopadol in the rat.
    Tzschentke TM; Rutten K
    Neuropharmacology; 2018 Feb; 129():100-108. PubMed ID: 29155273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of μ-opioid receptors and nociceptin/orphanin FQ peptide receptors in buprenorphine-induced physiological responses in primates.
    Cremeans CM; Gruley E; Kyle DJ; Ko MC
    J Pharmacol Exp Ther; 2012 Oct; 343(1):72-81. PubMed ID: 22743574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nociceptin/orphanin FQ receptor agonist Ro 64-6198 reduces alcohol self-administration and prevents relapse-like alcohol drinking.
    Kuzmin A; Kreek MJ; Bakalkin G; Liljequist S
    Neuropsychopharmacology; 2007 Apr; 32(4):902-10. PubMed ID: 16880770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ro 64-6198 [(1S,3aS)-8-(2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one] acts differently from nociceptin/orphanin FQ in rat periaqueductal gray slices.
    Chiou LC; Chuang KC; Wichmann J; Adam G
    J Pharmacol Exp Ther; 2004 Nov; 311(2):645-51. PubMed ID: 15254141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the NOP agonist SCH221510 on producing and attenuating reinforcing effects as measured by drug self-administration in rats.
    Sukhtankar DD; Lagorio CH; Ko MC
    Eur J Pharmacol; 2014 Dec; 745():182-9. PubMed ID: 25446568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nociceptin/orphanin FQ receptors modulate the discriminative stimulus effects of oxycodone in C57BL/6 mice.
    Walentiny DM; Wiebelhaus JM; Beardsley PM
    Drug Alcohol Depend; 2018 Jun; 187():335-342. PubMed ID: 29705547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the NOP receptor agonist Ro65-6570 on the acquisition of opiate- and psychostimulant-induced conditioned place preference in rats.
    Rutten K; De Vry J; Bruckmann W; Tzschentke TM
    Eur J Pharmacol; 2010 Oct; 645(1-3):119-26. PubMed ID: 20674566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic interaction between the agonism of cebranopadol at nociceptin/orphanin FQ and classical opioid receptors in the rat spinal nerve ligation model.
    Christoph T; Raffa R; De Vry J; Schröder W
    Pharmacol Res Perspect; 2018 Dec; 6(6):e00444. PubMed ID: 30519474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel, Orally Bioavailable Nociceptin Receptor Antagonist, LY2940094, Reduces Ethanol Self-Administration and Ethanol Seeking in Animal Models.
    Rorick-Kehn LM; Ciccocioppo R; Wong CJ; Witkin JM; Martinez-Grau MA; Stopponi S; Adams BL; Katner JS; Perry KW; Toledo MA; Diaz N; Lafuente C; Jiménez A; Benito A; Pedregal C; Weiss F; Statnick MA
    Alcohol Clin Exp Res; 2016 May; 40(5):945-54. PubMed ID: 27084498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanical hyperalgesia in rats with diabetic polyneuropathy is selectively inhibited by local peripheral nociceptin/orphanin FQ receptor and µ-opioid receptor agonism.
    Schiene K; Tzschentke TM; Schröder W; Christoph T
    Eur J Pharmacol; 2015 May; 754():61-5. PubMed ID: 25697471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of nociceptin/orphanin FQ peptide receptors disrupts visual but not auditory sensorimotor gating in BALB/cByJ mice: comparison to dopamine receptor agonists.
    Ces A; Reiss D; Walter O; Wichmann J; Prinssen EP; Kieffer BL; Ouagazzal AM
    Neuropsychopharmacology; 2012 Jan; 37(2):378-89. PubMed ID: 21881568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the NOP receptor signaling affects resilience to acute stress.
    Holanda VAD; Pacifico S; Azevedo Neto J; Finetti L; Lobão-Soares B; Calo G; Gavioli EC; Ruzza C
    J Psychopharmacol; 2019 Dec; 33(12):1540-1549. PubMed ID: 31337258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nociceptin/orphanin FQ receptor (NOP) agonist, Ro64-6198, on reactivity to acute pain in mice: comparison to morphine.
    Reiss D; Wichmann J; Tekeshima H; Kieffer BL; Ouagazzal AM
    Eur J Pharmacol; 2008 Jan; 579(1-3):141-8. PubMed ID: 18031727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The opioid receptor like-1 receptor agonist Ro 64-6198 (1S,3aS-8-2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one) produces a discriminative stimulus in rats distinct from that of a mu, kappa, and delta opioid receptor agonist cue.
    Recker MD; Higgins GA
    J Pharmacol Exp Ther; 2004 Nov; 311(2):652-8. PubMed ID: 15226383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.